Skip to main content

Testing for Covid-19 Infection

Testing people for Covid-19 infection is an essential component of our strategy to control the global Covid-19 pandemic. These tests come in two main groups: antigen tests and antibody tests.

The antigen test is to determine if you currently have Covid-19 infection. This requires swabs to be taken from your nose and throat to look for the presence of the SARS-CoV-2 virus that causes Covid-19 infection. In the UK, this test is mainly limited to hospital patients and NHS staff. There are now plans to extend testing to staff working in care homes. We will also need to expand testing to people in the community who do not require hospital treatment.

The antibody test to determine if you have had a previous Covid-19 infection. This is done through a blood test that is then assessed for the presence of antibodies to SARS-CoV-2. We believe that once people have been infected and develop antibodies, they should be protected from a repeat infection.

Because Covid-19 is a new disease, we don’t know how long this immunity lasts. If you have been infected, don’t assume you can’t get a repeat infection. Continue with preventive measures such as good personal hygiene and social distancing to reduce your risk and the risk to others.



Comments

Popular posts from this blog

What is the difference between primordial prevention and primary prevention?

Primordial prevention and primary prevention are both crucial strategies for promoting health, but they operate at different levels. Primordial prevention aims to address the root causes of health problems and improve the wider determinants of health. It focuses on preventing the emergence of risk factors in the first place by tackling the underlying social, economic, and environmental determinants of health. This involves broad, population-wide interventions such as: Policies that promote healthy food choices: Think about initiatives like taxing sugary drinks to discourage unhealthy consumption, or providing subsidies for fruits and vegetables to make them more accessible. Urban planning that prioritises well-being: This could include creating walkable neighborhoods with safe cycling routes, ensuring access to green spaces for recreation and relaxation, and designing communities that foster social connections. Social programs that address inequality: Initiatives aimed at reducing pov...

New NHS community mental health centres in England

The Government has announced it will create over 100 new community mental health centres across England, which will work alongside GPs and other NHS organisations/ The centres will offer offer walk-in support as well as seeing patients referred from elsewhere in the NHS. GPs have long called for faster access to specialist mental health support for patients, so the expansion of community mental health services is a welcome development. If these new centres improve access to multidisciplinary teams, reduce waiting times and provide more integrated care, they can improve patient outcomes while reducing pressure on both general practice and specialist mental health services. Close collaboration between GPs, mental health professionals, social care and the voluntary sector will be essential because many people with mental health problems also have wider social and physical health needs. The success of these centres will depend on how they are implemented. They need to be adequately staffe...

Protecting Young People from Meningococcal B Disease: The NHS Targeted Vaccination Programme

Meningococcal group B (MenB) infections are rare but can have devastating consequences. The decision to offer a targeted two-dose vaccination programme to Year 13 students and young people entering university or residential further education reflects concerns about recent outbreaks of meningococcal disease and the higher risk of transmission when large numbers of young adults mix closely for the first time in shared accommodation. The MenB vaccine has a well-established safety record, and evidence from the UK infant immunisation programme has shown substantial reductions in disease among vaccinated children. A targeted programme for those entering higher-risk settings is therefore a reasonable precautionary measure while further evidence is gathered on whether the recent increase in clusters represents a temporary fluctuation in disease patterns or a more sustained change in the epidemiology of MenB infection. The success of the programme will depend on achieving high uptake and ensuri...